Alaunos Therapeutics's total assets for Q1 2025 were $2.12M, a decrease of -23.05% from the previous quarter. TCRT total liabilities were $1.06M for the fiscal quarter, a 53.47% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.